Tuberculous Meningitis (TBM) is the infection of the meninges by Mycobacterium tuberculosis (Mtb) [1]. First described by Green in 1836 [2], TBM is the most common form of central nervous system tuberculosis (TB), accounting for 5-6% of extrapulmonary TB cases and for 1% of the total TB cases worldwide [1,3,4]. TBM is described as a subacute illness with a duration of symptoms that ranges 5-30 days with clinical features such as a low-grade fever, headache, and signs of meningeal irritation; in advanced stages, there may be focal neurological deficits, cranial nerve paralysis, and seizures [1,5,6]. The global incidence of TBM is unknown [7]; in 2017, Mexico had an overall prevalence of 0.35 cases per 100,000 inhabitants [8]. The global HIV epidemic has increased the number of adults affected by TBM. Data from a study that included a database of 1699 adult patients from five different studies reported a mortality rate of 23% in non-HIV patients and 51.3% for HIV-infected patients [9], reaching 100% in cases of drug-resistant Mtb [3]. Despite its high incidence, to our knowledge, the clinical features and outcome of the Mexican adult population with TBM have not been described. The aim of this study is to describe the characteristics at admission and in-hospital outcome of adult Mexican patients with TBM and compare them according to the subtype of diagnosis.